← Leaderboards
Annette M Molinaro
Yale University
$5,487,380
Attributed
$5,988,155
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $786.7K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,988,155 · 6
By mechanism
P50$4,232,209 · 4
R01$1,277,677 · 1
K22$478,269 · 1
Top collaborators
- Michael Krauthammer6 shared
Most similar at Yale University
Same institution · by research overlap
- David Pitt$7,740,406
- Michael Krauthammer$5,609,799
- Naila Makhani$791,857
- David L Rimm$13,301,493
- Joanne McGloin$606,420
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignClinical TrialsBiometryBioinformaticsData ManagementProtocols DocumentationData AnalysesGrantProgramsResearch PersonnelBiological MarkersOpen SourceMalignant NeoplasmsCommunitiesResourcesTechnologyMeetingsMemberBrain NeoplasmsScheduleMaintenanceMethodologyModalityEpidemiology
Grant awards (24)
Project 1: DNA Methylation-Based Blood Biomarkers for Prognosis, Molecular Stratification and Treatment Response in Glioma Patients$613,285
P50 · FY2025 · CA · contact PI
Core 2: Biostatistical and Clinical Core$173,367
P50 · FY2025 · CA · contact PI
Project 1: DNA Methylation-Based Blood Biomarkers for Prognosis, Molecular Stratification and Treatment Response in Glioma Patients$591,452
P50 · FY2024 · CA · contact PI
Core 2: Biostatistical and Clinical Core$167,196
P50 · FY2024 · CA · contact PI
Project 1: DNA Methylation-Based Blood Biomarkers for Prognosis, Molecular Stratification and Treatment Response in Glioma Patients$586,159
P50 · FY2023 · CA · contact PI
Core 2: Biostatistical and Clinical Core$165,701
P50 · FY2023 · CA · contact PI
BIOSTATISTICS AND CLINICAL CORE$228,483
P50 · FY2017 · CA · contact PI
Bioinformatics/Biostatistics Core$73,459
P50 · FY2017 · CA
BIOSTATISTICS AND CLINICAL CORE$195,932
P50 · FY2016 · CA · contact PI
Bioinformatics/Biostatistics Core$177,203
P50 · FY2016 · CA
Novel Tree-based Statistical Methods for Cancer Risk Prediction$324,939
R01 · FY2015 · CA · contact PI
Bioinformatics/Biostatistics Core$179,088
P50 · FY2015 · CA
BIOSTATISTICS AND CLINICAL CORE$173,861
P50 · FY2015 · CA · contact PI
Novel Tree-based Statistical Methods for Cancer Risk Prediction$314,257
R01 · FY2014 · CA · contact PI
Bioinformatics/Biostatistics Core$176,158
P50 · FY2014 · CA
BIOSTATISTICS AND CLINICAL CORE$166,309
P50 · FY2014 · CA · contact PI
Novel Tree-based Statistical Methods for Cancer Risk Prediction$302,880
R01 · FY2013 · CA · contact PI
Bioinformatics/Biostatistics Core$192,473
P50 · FY2013 · CA
BIOSTATISTICS AND CLINICAL CORE$168,913
P50 · FY2013 · CA · contact PI
Novel Tree-based Statistical Methods for Cancer Risk Prediction$335,601
R01 · FY2012 · CA · contact PI
Bioinformatics/Biostatistics Core$203,170
P50 · FY2012 · CA
Statistical Methods for Predicting Survival Outcomes from Genomic Data$159,575
K22 · FY2008 · CA · contact PI
Statistical Methods for Predicting Survival Outcomes from Genomic Data$159,521
K22 · FY2007 · CA · contact PI
Statistical Methods for Predicting Survival Outcomes from Genomic Data$159,173
K22 · FY2006 · CA · contact PI